Ts of lipid composition. Pharm Res 1990, 7:1127?133. 15. Desai TR, Hancock RE, Finlay WH: Delivery of liposomes in dry powder kind: aerodynamic dispersion properties. Eur J Pharm Sci 2003, 20:459?67. 16. Jaspart S, Bertholet P, Piel G, Dogn?J-M, Delattre L, Evrard B: Solid lipid microparticles as a sustained release program for pulmonary drug delivery. Eur J Pharm Biopharm 2007, 65:47?six. 17. Sebti T, Amighi K: Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J of Pharm Biopharm 2006, 63:51?8. 18. M ler RH, M er K, Gohla S: Solid lipid nanoparticles (SLN) for controlled drug delivery overview from the state of your art. Eur J Pharm Biopharm 2000, 50:161?77. 19. Trotta M, Cavalli R, Carlotti M, Battaglia L, Debernardi F: Strong lipid microparticles carrying insulin formed by solvent-in-water emulsion iffusion approach. Int J Pharm 2005, 288:281?88. 20. Pilcer G, Sebti T, Amighi K: Formulation and characterization of lipidcoated tobramycin particles for dry powder inhalation.29166-72-1 Data Sheet Pharm Res 2006, 23:931?40.578729-05-2 site 21. Masters K: Spray drying handbook. 5th edition. New York: Longman; 1991. 22. Steckel H, Brandes HG: A novel spray-drying approach to create low density particles for pulmonary delivery. Int J Pharm 2004, 278:187?95. 23. Chow AH, Tong HH, Chattopadhyay P, Shekunov BY: Particle engineering for pulmonary drug delivery. Pharm Res 2007, 24:411?37. 24. Son Y-J, McConville JT: Advancements in dry powder delivery towards the lung. Drug Dev Ind Pharm 2008, 34:948?59. 25. Sanna V, Kirschvink N, Gustin P, Gavini E, Roland I, Delattre L, Evrard B: Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech 2004, 5:17?three. 26. Nassimi M, Schleh C, Lauenstein H, Hussein R, Hoymann H, Koch W, Pohlmann G, Krug N, Sewald K, Rittinghausen S: A toxicological evaluation of inhaled solid lipid nanoparticles made use of as a prospective drug delivery method for the lung. Eur J Pharm Biopharm 2010, 75:107?16. 27. Smolensky M, D’alonzo G, Kunkel G, Barnes P: Day-night patterns in bronchial patency and dyspnea: basis for once-daily and unequally divided twice-daily theophylline dosing schedules. Chronobiol Int 1987, 4:303?17. 28. Chew NY, Shekunov BY, Tong HH, Chow AH, Savage C, Wu J, Chan HK: Effect of amino acids on the dispersion of disodium cromoglycate powders.PMID:25955218 J Pharm Sci 2005, 94:2289?300. 29. Salama RO, Traini D, Chan H-K, Young PM: Preparation and characterisation of controlled release co-spray dried drug olymer microparticles for inhalation two: Evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur J Pharm Biopharm 2008, 70:145?52. 30. Al-Asheh S, Jumah R, Banat F, Hammad S: The usage of experimental factorial design and style for analysing the impact of spray dryer operating variables on the production of tomato powder. Food Bioprod Procedure 2003, 81:81?eight. 31. St l K, Claesson M, Lilliehorn P, Lind H, B kstr K: The impact of method variables on the degradation and physical properties of spray dried insulin intended for inhalation. Int J Pharm 2002, 233:227?37. 32. Vehring R: Pharmaceutical particle engineering by way of spray drying. Pharm Res 2008, 25:999?022. 33. LechugaBallesteros D, Charan C, Stults CL, Stevenson CL, Miller DP, Vehring R, Tep V, Kuo MC: Trileucine improves aerosol performance and stability of spraydried powders for inhalation. J Pharm Sci 2008, 97:287?02. 34. Srichana T, Brain A, Marriott C, Martin GP: A study of.